Table 6.
Correlation of clinical investigations with telomere length and Vitamin D in diabetic subjects
| Variable | TL | Vitamin D | ||
|---|---|---|---|---|
|
|
|
|||
| rho | P | r | P | |
| Age | 0.20 | 0.1840 | -0.05 | 0.718 |
| BMI | -0.39 | 0.0083 | -0.25 | 0.0470 |
| Duration of T2DM | 0.13 | 0391 | -0.32 | 0.0165 |
| WHR | -0.28 | 00332 | -0.02 | 09033 |
| HbA1c (%) | -0.99 | <0.0001 | 0.08 | 05897 |
| FBS (mg/dl) | -0.97 | <0.0001 | 0.06 | 0.7184 |
| PPBS (mg/dl) | -0.98 | <0.0001 | 0.05 | 0.7646 |
| Serum creatinine (mg/dl) | -0.05 | 0.7316 | -0.31 | 0.0381 |
| Total leukocyte count | 0.01 | 0.9472 | -0.14 | 03299 |
| Vitamin D | 0.11 | 0.4594 | - | - |
Rho: Spearman rank correlation, r: Pearson correlation coefficient. BMI: Body mass index, WHR: Waist-hip-ratio, HbA1c: Glycated hemoglobin, FBS: Fasting blood sugars, PPBS: Postprandial blood sugar, T2DM: Type 2 diabetes mellitus, TL: Telomere length